CY1110507T1 - ΝΕΟ ΠΕΠΤΙΔΙΟ ΤΟ ΟΠΟΙΟ ΑΛΛΗΛΕΠΙΔΡΑ ΜΕ ΤΙΣ ΑΝΤΙ-ΑΠΟΠΤΩΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΤΗΣ ΟΙΚΟΓΕΝΕΙΑΣ Bcl-2 - Google Patents
ΝΕΟ ΠΕΠΤΙΔΙΟ ΤΟ ΟΠΟΙΟ ΑΛΛΗΛΕΠΙΔΡΑ ΜΕ ΤΙΣ ΑΝΤΙ-ΑΠΟΠΤΩΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΤΗΣ ΟΙΚΟΓΕΝΕΙΑΣ Bcl-2Info
- Publication number
- CY1110507T1 CY1110507T1 CY20091100883T CY091100883T CY1110507T1 CY 1110507 T1 CY1110507 T1 CY 1110507T1 CY 20091100883 T CY20091100883 T CY 20091100883T CY 091100883 T CY091100883 T CY 091100883T CY 1110507 T1 CY1110507 T1 CY 1110507T1
- Authority
- CY
- Cyprus
- Prior art keywords
- bcl
- interacts
- proteins
- doping
- family
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000051485 Bcl-2 family Human genes 0.000 title 1
- 108700038897 Bcl-2 family Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 abstract 1
- 108700000711 bcl-X Proteins 0.000 abstract 1
- 102000055104 bcl-X Human genes 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Η εφεύρεση στηρίζεται επί της ταυτοποίησης ενός νέου πεπτιδίου το οποίο αλληλεπιδρά με τις αντι-αποπτωτικές πρωτεΐνες Bcl-2, Bcl-W και/ή Bcl-XL, καθώς και επί των μεθόδων διαλογής που επιτρέπουν την ταυτοποίηση διαμορφωτών αυτών των αλληλεπιδράσεων.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0309697A FR2858621B1 (fr) | 2003-08-06 | 2003-08-06 | Nouveau peptide interagissant avec bcl-xl et bcl-2 |
| EP04786256A EP1651668B1 (fr) | 2003-08-06 | 2004-08-04 | Nouveau peptide interagissant avec les proteines anti-apoptotiques de la famille bcl-2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110507T1 true CY1110507T1 (el) | 2015-04-29 |
Family
ID=34073058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20091100883T CY1110507T1 (el) | 2003-08-06 | 2009-08-20 | ΝΕΟ ΠΕΠΤΙΔΙΟ ΤΟ ΟΠΟΙΟ ΑΛΛΗΛΕΠΙΔΡΑ ΜΕ ΤΙΣ ΑΝΤΙ-ΑΠΟΠΤΩΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΤΗΣ ΟΙΚΟΓΕΝΕΙΑΣ Bcl-2 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7459434B2 (el) |
| EP (1) | EP1651668B1 (el) |
| JP (1) | JP4395514B2 (el) |
| CN (1) | CN1829737B (el) |
| CA (1) | CA2533557A1 (el) |
| CY (1) | CY1110507T1 (el) |
| DE (1) | DE602004022053D1 (el) |
| DK (1) | DK1651668T3 (el) |
| ES (1) | ES2330007T3 (el) |
| FR (1) | FR2858621B1 (el) |
| HR (1) | HRP20090481T1 (el) |
| PL (1) | PL1651668T3 (el) |
| PT (1) | PT1651668E (el) |
| SI (1) | SI1651668T1 (el) |
| WO (1) | WO2005014638A2 (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2881430B1 (fr) * | 2005-02-01 | 2010-10-22 | Servier Lab | Nouveaux peptides interagissant avec les membres anti-apoptotiques de la famille de proteines bcl-2 et utilisations |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283173A (en) * | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| WO2002072761A2 (en) * | 2001-03-08 | 2002-09-19 | Phylos, Inc. | Polypeptides interactive with bcl-x¿l? |
-
2003
- 2003-08-06 FR FR0309697A patent/FR2858621B1/fr not_active Expired - Fee Related
-
2004
- 2004-08-04 US US10/566,668 patent/US7459434B2/en not_active Expired - Fee Related
- 2004-08-04 PT PT04786256T patent/PT1651668E/pt unknown
- 2004-08-04 SI SI200431194T patent/SI1651668T1/sl unknown
- 2004-08-04 DK DK04786256T patent/DK1651668T3/da active
- 2004-08-04 JP JP2006522376A patent/JP4395514B2/ja not_active Expired - Fee Related
- 2004-08-04 CN CN2004800217997A patent/CN1829737B/zh not_active Expired - Fee Related
- 2004-08-04 EP EP04786256A patent/EP1651668B1/fr active Active
- 2004-08-04 PL PL04786256T patent/PL1651668T3/pl unknown
- 2004-08-04 WO PCT/FR2004/002081 patent/WO2005014638A2/fr active Application Filing
- 2004-08-04 DE DE602004022053T patent/DE602004022053D1/de active Active
- 2004-08-04 ES ES04786256T patent/ES2330007T3/es active Active
- 2004-08-04 CA CA002533557A patent/CA2533557A1/fr not_active Abandoned
-
2009
- 2009-08-20 CY CY20091100883T patent/CY1110507T1/el unknown
- 2009-09-09 HR HR20090481T patent/HRP20090481T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1651668E (pt) | 2009-08-21 |
| FR2858621B1 (fr) | 2007-09-07 |
| US7459434B2 (en) | 2008-12-02 |
| CN1829737A (zh) | 2006-09-06 |
| JP2007529193A (ja) | 2007-10-25 |
| HRP20090481T1 (hr) | 2009-10-31 |
| JP4395514B2 (ja) | 2010-01-13 |
| WO2005014638A3 (fr) | 2005-06-09 |
| FR2858621A1 (fr) | 2005-02-11 |
| EP1651668A2 (fr) | 2006-05-03 |
| ES2330007T3 (es) | 2009-12-03 |
| WO2005014638A2 (fr) | 2005-02-17 |
| CA2533557A1 (fr) | 2005-02-17 |
| CN1829737B (zh) | 2012-10-10 |
| US20060183688A1 (en) | 2006-08-17 |
| DK1651668T3 (da) | 2009-10-19 |
| PL1651668T3 (pl) | 2010-01-29 |
| SI1651668T1 (sl) | 2009-12-31 |
| EP1651668B1 (fr) | 2009-07-15 |
| DE602004022053D1 (de) | 2009-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124118T1 (el) | Αντισωματα προσδεσης θυμικης στρωματικης λεμφοποιητινης (tslp) και μεθοδοι χρησης των αντισωματων | |
| CY1120424T1 (el) | Πεπτιδια λαμβανομενα απο ανθρωπινη bplp πρωτεϊνη, πολυνουκλεοτιδια που κωδικοποιουν τα εν λογω πεπτιδια και αντισωματα κατευθυνομενα εναντι των εν λογω πεπτιδιων | |
| CY1124518T1 (el) | Μεταλλαγες πρωτεϊνης φακελου hiv που σταθεροποιουν το τριμερες | |
| CY1118980T1 (el) | Στερεες μορφες ν-[2,4-δις(1,1-διμεθυλαιθυλ)-5-υδροξυφαινυλ]-1,4-διυδρο-4-οξοκινολινο-3-καρβοξαμιδιου | |
| EA202192738A1 (ru) | Трициклические соединения, обеспечивающие разрушение белка ikaros и белка aiolos | |
| CY1111798T1 (el) | Οδοντοβουρτσα | |
| CY1116913T1 (el) | Τροποποιημενα κλασματα fab αντισωματων | |
| CR20210154A (es) | Moléculas de unión a antígeno bioespecíficas que comprenden el clon 212 anti-fap | |
| RU2013119417A (ru) | Антигенсвязывающие молекулы, которые связывают egfr, кодирующие их векторы и их применение | |
| CY1114626T1 (el) | Μεθοδοι κυκλοπολυαιθυλενογλυκολιωσης και πρωτεϊνες/πεπτιδια που παραγονται με αυτες τις μεθοδους | |
| CY1114916T1 (el) | Μεθοδοι | |
| EA200702643A1 (ru) | Антитела, связывающие tweak | |
| CY1113713T1 (el) | Ανοσοκατασταλτικα πολυπεπτιδια και νουκλεϊκα οξεα | |
| WO2005060377A3 (en) | Modulation of immunostimulatory properties by small oligonucleotide-based compounds | |
| CY1109465T1 (el) | Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης | |
| ATE414535T1 (de) | Trägerproteine für impfstoffe | |
| ATE531529T1 (de) | Wertdokument, herstellung und prüfung von wertdokumenten | |
| MX2022002111A (es) | Novedosos anticuerpos anti-cldn18.2. | |
| EA201992281A1 (ru) | Связывающие молекулы, специфично связывающиеся с тау-белком | |
| CY1105980T1 (el) | Βελτιωμενη διαδικασια παρασκευης υδροβρωμικου αλατος του αλφα-πολυμορφικου ελετριπτανιου | |
| CU20200054A7 (es) | Composiciones de edb que se dirigen a il-12 | |
| CY1108226T1 (el) | Αντικαρκινικες ενωσεις βασισμενες σε καχαλαλιδης f | |
| MX2022010350A (es) | Composiciones de esquerichia coli y sus metodos. | |
| CL2020003391A1 (es) | Proteína de unión al antígeno anti-steap1 | |
| CY1126075T1 (el) | Αντισωμα που περιλαμβανει μια c-τελικη επεκταση ελαφρας αλυσιδας που περιλαμβανει γλουταμινη, συζευγματα αυτου, και μεθοδοι και χρησεις |